Skip to Content
Current OncologyCurrent Oncology
  • Article
  • Open Access

1 February 2011

10 Pages

Immune Therapy for Breast Cancer in 2010—Hype or Hope?

,
,
and
1
Division of Medical Oncology and Hematology, Princess Margaret Hospital, and Department of Medicine, University of Toronto, Toronto, ON, Canada
2
Division of Medical Oncology, The Ottawa Hospital Cancer Centre, and Department of Medicine, University of Ottawa, Box 912, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada
*
Author to whom correspondence should be addressed.

Abstract

The identification of numerous breast cancer antigens has generated increasing enthusiasm for the application of immune-based therapies in breast malignancies. Although the use of monoclonal antibodies has revolutionized the “targeted therapy” of breast cancer, and the immunomodulatory effects of bisphosphonates continue to be evaluated, few studies to date have demonstrated widespread utility for other forms of immunotherapy. The present review assesses modern research and explores whether the hopes for immunotherapy can overcome the hype.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.